BioMarin to open additional phase III studies based on phase I/II data of BMN-270 Aug. 3, 2017 No Comments
MHCSZ-123 antibody offers strong antithrombotic effects by inhibition of collagen binding July 31, 2017 No Comments
FDA grants fast track designation to caplacizumab for acquired thrombotic thrombocytopenic purpura July 26, 2017 No Comments
Ono Pharmaceutical presents promising in vitro and preclinical data for ONO-5450598 July 26, 2017 No Comments
RSS